"We have a hands-off highway feature that we're going to be launching here very soon, you know, within the next several weeks ...

sending its shares up 2.2% premarket. Regeneron beats quarterly estimates on eczema drug demand; launches dividend program Sanofi said on Thursday it would buy back 5 billion euros ($5.21 billion ...

Biopharma doubles down on immunology and inflammation as companies target new pathways and seek to improve on current options ...

SAN FRANCISCO, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is facing mounting pressure on multiple fronts. Following disappointing sales figures and ongoing ...

Remember the iPod shuffle? When it was launched, it opened up the MP3 player to a much wider audience, thanks to its compact dimensions and affordable pricing – and the Volkswagen ID 2 is aiming ...

Parents are often searching for the automotive holy grail: a car that’s not a minivan and can fit three child-safety seats across the backseat. In our Car Seat Checks, we’ve found the answer ...

The quarter saw Regeneron grow its revenue by 10% year over year to just under $3.79 billion. Although non-GAAP (adjusted) net income didn't rise as precipitously, it did improve, gaining 2% to $1 ...

Regeneron’s shares have lost 28.8% in the past year compared with the industry’s decline of 9%. Eylea’s sales in the United States declined 11% year over year to $1.2 billion, primarily due ...

Regeneron paid credit card fees to distributors on the condition that distributors did not charge, one of the Company's primary products, Eylea customers more to use a credit card; (2) these ...

TARRYTOWN, N.Y. (AP) — TARRYTOWN, N.Y. (AP) — Regeneron Pharmaceuticals Inc ... Revenue was reported as $14.2 billion. This story was generated by Automated Insights (http ...